Articles

Multiple System Atrophy Therapeutics is an evolving field focused on treating a rare neurodegenerative disease with no cure. This article examines the Multiple System Atrophy Therapeutics Market, its size, growth drivers, recent product development, regional trends, key players, and what lies ahead up to 2033—based largely on the report by Acumen Research And Consulting.
What is Multiple System Atrophy and the Role of Therapeutics Multiple System Atrophy (MSA) is a progressive, rare neurodegenerative disorder adversely affecting the autonomic nervous system, movement, balance, coordination, and various bodily functions. Patients experience tremor, parkinsonian symptoms, cerebellar dysfunction, autonomic dysregulation (blood pressure, bladder control), and rapidly declining ability to perfor…

Explore how to become a research nurse - gain clinical experience, develop trial skills, earn certifications, and enter a career at the forefront of medical innovation.
Research nurses play a pivotal role in bridging clinical care with scientific discovery, offering registered nurses (RNs) a rewarding alternative to traditional nursing. Their work supports the development of new treatments and enhances patient outcomes by conducting clinical trials and ensuring data integrity. Step-by-Step Guide to Becoming a Research Nurse 1. Build Clinical Experience:Begin with at least two years of hands-on nursing, ideally in high-impact areas like oncology, cardiology, or infectious diseases. 2. Develop Key Research Skills:Critical thinking, protocol adherence, data collection, and patient recruitmen…

Richard Corbridge - UK CIO and BCS Fellow
The UK is at a pivotal moment in its digital journey. With more than £40 billion of fresh commitments from global technology leaders like Google, Microsoft, Nvidia, Salesforce and OpenAI, the country has earned a mandate to prove that it can convert tech investment into meaningful, sustainable transformation, according to leading UK CIO and BCS Fellow, Richard Corbridge. Richard Corbridge commented: “The next phase of UK technology growth depends not only on AI algorithms and software, but also on the infrastructure, skills, and trust frameworks that enable them to thrive. Energy resilience, advanced connectivity, and ethical governance will determine…

In pharmaceutical production, powders often have to be dispersed into liquids. Conventional technology often achieves only incomplete wetting, because the powders are introduced in agglomerated form. One solution is modern vacuum technology, by which the particles can be wetted separately.
The production or refinement of pharmaceutical products often involves dispersing dusty, sticky or fine powders into liquids. When using conventional technology, this often leads to problems - for example, when agglomerated powders are not completely wetted. This is precisely where modern vacuum dispersing systems come in.    Pharmaceutical products manufactured on the basis of powders or refined by powders include gels, ointments and suspensions, or tablet coatings. For these products, many di…

Author: Sina Bari, AVP - Medical AI, iMerit Inc
The hype surrounding medical AI often conjures images of powerful algorithms operating out of the clusters of a remote datacenter, but in practice, building clinically-viable technology is far more grounded. For too long, AI followed a linear path: tech firms gathered data, built algorithms, and forced them into clinical workflows. This “black box” approach led to a high rate of failure. Models were often brittle, non-compliant, and could not handle the messiness of real-world patient data. They struggled with fragmented records, nuanced longitudinal histories, or the subjectivity in radiology reports. Today’s bottleneck isn’t compute but clinical validity and regulatory readin…

Article By Nicolas Wolikow, coFounder at Cure51.
In oncology, progress is often measured in small increments - a few additional months of survival, a slight improvement in quality of life, a percentage point gain in remission rates. While these steps are vital, they reflect an industry norm that focuses overwhelmingly on average patient outcomes. But hidden within the data are remarkable outliers: patients who, against all statistical odds, live far longer and better than expected. These “exceptional survivors” are not anomalies to be brushed aside; they are windows into the biology of resilience. Studying them deeply could reveal the mechanisms that transform certain cancers…

Case management workflow software modernizes pharmacological by digitizing workflows, reducing errors, and ensuring regulatory compliance. It speeds up case processing, improves accuracy, provides audit-ready data, and supports global scalability. By enabling collaboration and data-driven decisions, it transforms PV into a strategic advantage that safeguards patients and strengthens operational efficiency.
Pharmacovigilance (PV) as the cornerstone of drug safety, committed to safeguarding patient health by systematically monitoring, analyzing, and mitigating the risks associated with therapeutic products from pre-clinic stages through post-market oversight.As the innovation pipeline delivers a broader range of therapies, and as global clinical trials and ever-broader regulatory expectations…

The CBH Biospecimen Marketplace is an online biobank and biorepository built for teams who need human biological samples with audit-ready documentation and dependable logistics. Our continuously curated biological specimen inventory exceeds a quarter of a million active units and spans serum, plasma, whole blood, PBMC for research, urine samples, cerebrospinal fluid (CSF), saliva, stool/feces/faeces, swab samples, and human tissue (FFPE and frozen). You can search, filter, compare, and order human biospecimens for research, development, and production—not only RUO feasibility. What differentiates the platform is scientific traceability: standardized preanalytics, transparent biospecimen data, and route-proven cold-chain shipping.
  What Counts as a Human Biological Specimen? Human biol…

Nutrigenomics is reshaping how we understand the connection between genes and diet. This article explores how DNA insights can guide personalized nutrition, improve long-term wellness strategies, and empower individuals to make informed lifestyle choices. With privacy-first, on-device processing, Noorns provides a secure and innovative approach to DNA-based health insights, bridging science and everyday health.
Nutrigenomics, the study of how our genes interact with diet, is emerging as one of the most promising areas in personalized health. Genetic variations can influence how we metabolize nutrients, respond to supplements, and manage risks for chronic conditions. Understanding these patterns opens new opportunities for preventative care, optimized wellness strategies, and more targeted i…

Julie Hurvitz Aliaga, EVP, Innovation, Content and Partnerships, CMI Media Group shares her insights from the recent "Agility: Hype to Hope to Health" event which brought the reality of caregiving into sharp focus. Julie shares practical advice for healthcare marketers around the value of innovation, content and partnerships when speaking to both patients and their caregivers.
The healthcare landscape is undergoing a profound transformation, and at its heart lies an often overlooked, yet absolutely critical, figure: the caregiver. Our recent "Agility: Hype to Hope to Health" event brought this reality into sharp focus during our panel, "The Rise of the Caregiver." It was a privilege to moderate a discussion with such inspiring women – Dr. Robyn Roth, Radiologist and Founder of The Boobie D…

Design alone is no longer enough to bring transformative products to life. While great design sparks creativity and defines user experience, development is what turns vision into reality. At Hurdle, we believe that true innovation demands more than following a conventional design process-it requires a smarter, more holistic approach that aligns strategy, technology, and market readiness.
A successful design and development process must balance exploration with structure, enabling teams to build high-quality products efficiently while adapting to change along the way. Yet, while the traditional design process may comprise four to five defined phases, Hurdle believes there is more to consider from the outset. Elements such as business analysis, capability planning, budgetary controls, capabil…

Analytical method development and validation are essential for CRDMO success, ensuring accurate, reliable, and regulatory-compliant results from R&D to GMP manufacturing. Pharmaffiliates integrates ISO 17025-accredited lab services into its CRDMO model, offering capabilities like HPLC, LC-MS/MS, impurity profiling, stability testing, and method transfer. Validated methods enable consistent batch quality, faster scale-up, and streamlined regulatory compliance, helping clients accelerate drug development with confidence.
The Role of Analytical Method Development in CRDMO Success Why Analytics Is a Pillar of Pharmaceutical Development In today’s pharmaceutical environment, where compliance and speed-to-market are paramount, analytical method development and validation play a foun…

The United States Food and Drug Administration’s (FDA’s) Accelerated Approval (AA) pathway, initially established in 1992 during the HIV/AIDS epidemic to provide faster access to life-saving treatments, has been instrumental in expediting access to therapies for serious and life-threatening conditions. It is particularly significant in therapeutic areas, such as rare diseases, where surrogate or intermediate clinical endpoints may be necessary due to limited patient populations or slow disease progression. While this approach has encouraged innovation, it has also raised concerns about drugs staying on the market without confirmed evidence of their effectiveness.
The United States Food and Drug Administration’s (FDA’s) Accelerated Approval (AA) pathway, initially established in 1992 during…

Mobility equipment is often overlooked in elderly care, yet it plays a vital role in supporting independence, preventing falls, and improving health outcomes for seniors. From adjustable beds that aid circulation and breathing to scooters that reduce social isolation, assistive devices can significantly improve both physical and mental wellbeing. These solutions also ease the strain on carers, reducing injuries and stress in home and clinical settings. As healthcare systems look for ways to lower hospital admissions and promote preventive care, mobility equipment deserves recognition as an essential part of elderly care strategies. By making these tools more accessible, we can help older adults thrive while also reducing pressure on health services.
As populations age across the globe, heal…

By Erin Beveridge, Principal Clinical Researcher on the Imaging team at the AI centre of Excellence, Canon Medical Research Europe. Her primary research is in the fields of neuroradiology and women’s health.
The Urgent Need for Change Women’s Health isn’t a niche issue. It concerns the health of half the population. And yet, the gender gap in healthcare remains overlooked. Women’s Health issues have historically been under-researched, marginalised, and underserved. This systemic neglect has led to disparities in diagnosis, treatment, and overall health outcomes for women. Addressing these gaps is not just a matter of equality, it is a matter of equity and scientific necessity. The Male Default in Medicine On the face of it, it seems obvious that men and women are biologically different, an…

Orthobiologics are biologically derived therapies such as PRP, stem cells, and bone graft substitutes that enhance natural healing in orthopedics. They are used to treat fractures, tendon injuries, and degenerative joint disease.
Orthobiologics are biologically based therapies that support the body’s natural ability to heal musculoskeletal injuries. Derived from substances naturally found in the human body, they are increasingly used in orthopedics to accelerate recovery, reduce pain, and enhance surgical outcomes. With applications ranging from sports injuries to spinal fusion, orthobiologics are transforming how clinicians approach bone, tendon, ligament, and cartilage repair. What Are Orthobiologics? Orthobiologics use cells, growth factors, and biomaterials to promote healing at the…

3D bioprinting uses bio-inks made from living cells to create tissue-like structures for regenerative medicine, drug testing, and personalised implants. While challenges remain, it offers huge potential for future organ transplants.
3D bioprinting is redefining the boundaries of medical science, offering new possibilities in tissue engineering, regenerative medicine, and personalised healthcare. By using bio-inks composed of living cells, growth factors, and biomaterials, researchers can now print tissue-like structures that closely resemble the complexity of human organs. Unlike traditional 3D printing, which relies on plastics or metals, 3D bioprinting creates biological constructs layer by layer. The process typically begins with imaging and computer-aided design to create a digital blue…

Investigator-Initiated Trials have shifted from small academic projects to a powerful driver of clinical innovation. They address unmet patient needs, attract diverse funding, gain regulatory acceptance, and generate real-world evidence. However, investigators face barriers like regulatory complexity, operational burdens, funding gaps, and publication pressure. CROs play a crucial role by providing protocol design, regulatory navigation, trial operations, data management, safety monitoring, and publication support. For sponsors, IITs offer early innovation insights, post-marketing data, and stronger credibility
The Rise of Investigator-Initiated Trials: A CRO’s Guide to Enabling Innovation Investigator-initiated trials (IITs) have progressively shifted from specialized academic projec…

Clinical research studies are the backbone of medical progress this article explains five key types observational, longitudinal, cross-sectional, case-control and experimental helping you understand how each plays a role in advancing treatments and improving patient care.
Have you ever stopped to think about how a new medication gets from a scientist lab to your local pharmacy shelf? It is not just a guess or a hope it is a journey driven by the incredible power of data every medical breakthrough from a groundbreaking cancer treatment to a simple new vaccine is the result of painstaking and methodical work known as clinical research this field is all about asking the right questions and finding reliable answers that can change lives if you are fascinated by the science behind medicine or ar…